Stephan Ludwig
5PUBLICATIONS
12CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Feb 20, 2025
Influenza H5Nx viruses are susceptible to MEK1/2 inhibition by zapnometinib.André Schreiber, Nicole Oberberg, Benjamin Ambrosy
|Sep 23, 2022
The MEK1/2 Inhibitor ATR-002 (Zapnometinib) Synergistically Potentiates the Antiviral Effect of Direct-Acting Anti-SARS-CoV-2 Drugs.André Schreiber, Benjamin Ambrosy, Oliver Planz
|Jan 11, 2022
The MEK1/2-inhibitor ATR-002 efficiently blocks SARS-CoV-2 propagation and alleviates pro-inflammatory cytokine/chemokine responses.André Schreiber, Dorothee Viemann, Jennifer Schöning
|Sep 01, 2020
Discrete spatio-temporal regulation of tyrosine phosphorylation directs influenza A virus M1 protein towards its function in virion assembly.Angeles Mecate-Zambrano, Swathi Sukumar, Guiscard Seebohm
|Jul 01, 2020
Dissecting the mechanism of signaling-triggered nuclear export of newly synthesized influenza virus ribonucleoprotein complexes.André Schreiber, Laurita Boff, Darisuren Anhlan
Pageof 1
Frequent Collaborators
3 joint publications
Stephan Ludwig
2 joint publications
Linda Brunotte
2 joint publications
Benjamin Ambrosy
1 joint publications
Roland Wedlich-Söldner
1 joint publications
Hannes Drexler
1 joint publications
Angeles Mecate-Zambrano
1 joint publications
Oliver Planz
1 joint publications
Ursula Rescher
1 joint publications
Nicole Oberberg
1 joint publications
Franziska Rodner
